Anti-IL21 Neutralizing Antibody (V3S-1022-YC2991) (CAT#: V3S-1022-YC2991)

Send Inquiry
  • fig1
    Figure 1 Anti-IL21 Monoclonal Antibody (V3S-1022-YC2991) in WB
  • fig1
    Figure 2 Anti-IL21 Monoclonal Antibody (V3S-1022-YC2991) in DB
  • fig1
    Figure 3 Anti-IL21 Monoclonal Antibody (V3S-1022-YC2991) in ELISA

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description This product is a recombinant Human antibody provided by CreativeBiolabs. The antibody is specific for Interleukin 21. It can be used for Interleukin 21 detection in Enzyme-Linked Immunosorbent Assay and Neutralization Assay. It was expressed in mammalian cells (293F or CHO) with antibody encoding genes and purified by affinity chromatography. Each lot of this antibody is quality control tested by SDS-PAGE and SEC-HPLC analysis. For highly sensitive assays, we recommend the ultrapurified form of the product, which has a lower endotoxin limit than standard antibody, less than 1 EU/mg or even 0.1 EU/mg.
Clonality Monoclonal
Host Species Human
Target Species Human, Cynomolgus
Isotype IgG1

Property

Expression Species HEK293F or CHO Cell line
Conjugation Unconjugated, also available for Biotin, HRP, FITC and PE-labeled form.
Purity >95%, determined by SDS-PAGE and SEC-HPLC
Endotoxin <1 EU/mg, determined by LAL method
Purification Purified with Protein A or G affinity chromatography
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4°C within one or two weeks. Store at -20°C for long term. Avoid repeated freeze/thaw cycles. Refer to the COA file for specifics.

Applications

Application WB; DB; ELISA; Neut

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target IL21
Alternative Name Za11; IL-21; CVID11
Gene ID 59067
UniProt Q9HBE4
Research Area Immunology; Cancer Research
Related Disease Graft-versus-host disease (GVHD)

Tested Data

WB

Figure 1 Anti-IL21 Monoclonal Antibody (V3S-1022-YC2991) in WB

Western blot analysis of V3S-1022-YC2991 was performed by loading human IL21 protein (Lane 1 0.1 μg, Lane 2 0.3 μg, Lane 3 0.6 μg) onto a 12% Tris-HCl polyacrylamide gel. Proteins were transferred to a CN membrane and blocked with 5% skim milk for at least one hour. Membranes were probed with V3S-1022-YC2991 and HRP goat anti-human IgG as a secondary antibody (1: 3000). Chemiluminescent detection was performed.

Figure 1 Anti-IL21 Monoclonal Antibody (V3S-1022-YC2991) in WB

DB

Figure 2 Anti-IL21 Monoclonal Antibody (V3S-1022-YC2991) in DB

Dot Blot analysis of V3S-1022-YC2991 was performed by coating with human IL21 protein (His tag).

V3S-1022-YC2991 incubation concentration: 2 μg/mL.
HRP-conjugated goat anti-human IgG as a secondary antibody (1: 3000)

Figure 2 Anti-IL21 Monoclonal Antibody (V3S-1022-YC2991) in DB

ELISA

Figure 3 Anti-IL21 Monoclonal Antibody (V3S-1022-YC2991) in ELISA

ELISA analysis of V3S-1022-YC2991 was performed by coating with human IL21 protein (His tag). Then blocked with BSA and incubated with V3S-1022-YC2991. The HRP-conjugated goat anti-human IgG as a secondary antibody (1: 4000). Detection was performed using TMB substrate and stopped with sulfuric acid. The absorbances were read on a spectrophotometer at 450 nm.

Figure 3 Anti-IL21 Monoclonal Antibody (V3S-1022-YC2991) in ELISA

For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
Online Inquiry